Nathalie Conrad
Contact information
Research groups and committees
Funding
The Wellcome Trust, The British Heart Foundation, The European Union (Marie Skłodowska-Curie Actions), The Research Foundation Flanders (FWO).
Nathalie Conrad
MSc, DPhil, FESC
Senior Research Fellow
Research
Dr. Nathalie Conrad is a senior research fellow and principal investigator in health data science and epidemiology.
Dr. Conrad’s group focuses on large-scale data analyses to study cardiovascular disease epidemiology, disease trajectories and risk factors, with a particular focus on women’s cardiovascular health. Projects include investigations of women-specific risk factors in the development cardiovascular diseases, or the role of maternal health in the development of offspring congenital heart defects.
Major studies by Dr. Conrad and her group include research on cardiovascular risks in patients with autoimmune diseases, autoimmune disease epidemiology, long-term trends in cardiovascular disease burden, or the epidemiology of heart failure, investigating how sex and socio-economic differences impact disease incidence, care delivery and outcomes.
Dr. Conrad holds a PhD in medical sciences from Oxford University, an engineering Master’s degree from the Swiss Federal Institute of Technology (ETH Zurich), and previous work experience as a data analytics consultant at IBM.
Key publications
-
Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study
Conrad N. et al, (2024), BMJ, e078523 - e078523
-
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
Conrad N. et al, (2023), The Lancet, 401, 1878 - 1890
-
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
Conrad N. et al, (2022), The Lancet, 400, 733 - 743
-
Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls
Ferguson LD. et al, (2024), The Lancet Rheumatology, 6, e156 - e167